Thymic lymphomas in mice with a truncating mutation in BRCA2

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1338-1343

  Friedman, Lori S ^a   Thistlethwaite, Fiona C ^a   Patel, Ketan J ^b   Yu, Veronica P C C ^b   Lee, Hyunsook ^b   Venkitaraman, Ashok R ^b   Abel, Kenneth J ^c   Carlton, Mark B L ^a   Hunter, Susan M ^a   Colledge, William H ^a   Evans, Martin J ^a   Ponder, Bruce A J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c CELERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE MUTATION; GENETIC RISK; GENOTYPE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS LYMPHOMA; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; BRCA2 PROTEIN; EXONS; GENOTYPE; HOMOZYGOTE; HUMANS; LYMPHOMA; MICE; MICE, INBRED C57BL; MUTATION; NEOPLASM PROTEINS; PHENOTYPE; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 0032054158     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B. A. J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Egilsson, V., Barkardottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A., and Stratton, M. R: Identification of the breast cancer susceptibility gene BRCA2. Nature (Lond.), 378: 789-792, 1995.
2. Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., Lakhani, S. R., Ormiston, W., Daly, P. A., Ford, D., Easton, D. F., and Stratton, M. R. Consistent loss of the wild-type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene, 10: 1673-1675, 1995.
3. Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A. J., Stratton, M. R., and Easton, D. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet., 15: 103-105, 1997.
4. Jensen, R. A., Thompson, M. E., Jetton, T. L., Szabo, C. I., Vandermeer, R., Helou, B., Tronick, S. R., Page, D. L., King, M. C., and Holt, J. T. BRCA1 is secreted and exhibits properties of a granin. Nat. Genet., 12: 303-308, 1996.
5. Bignell, G., Micklem, G., Stratton, M. R., Ashworth, A., and Wooster, R. The BRC repeats are conserved in mammalian BRCA2 proteins. Hum. Mol. Genet., 6: 53-58, 1997.
6. Milner, J., Ponder, B., Hughes-Davies, L., Seltmann, M., and Kouzarides, T. Transcriptional activation functions in BRCA2. Nature (Lond.), 386: 772-773, 1997.
7. Wong, A. K. C., Pero, R., Ormonde, P. A., Tavtigian, S. V., and Bartel, P. L. RAD51 interacts with the evolutionarily conserved BRG motifs in the human breast cancer susceptibility gene BRCA2. J. Biol. Chem., 272: 31941-31944, 1997.
8. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (Lond.), 386: 804-810, 1997.
9. Ludwig, T., Chapman, D. L., Papaioannou, V. E., and Efstratiadis, A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev., 11: 1226-1241, 1997.
10. Suzuki, A., de la Pompa, J. L., Hakem, R., Elia, A., Yoshida, R., Mo, R., Nishina, H., Chuang, T., Wakeham, A., Itie, A., Koo, W., Billia, P., Ho, A., Fukumoto, M., Hui, C. C., and Mak, T. W. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev., 11: 1242-1252, 1997.
11. Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulewicz, V. L. J., and Ashworth, A. Tumorigenesis and a DNA repair defect in mice with truncated Brca2. Nat. Genet., 17: 423-430, 1997.
12. Abel, K. J., Xu, J., Yin, G-Y., Lyons, R. H., Meisler, M. H., and Weber, B. L. Mouse Brca1: localization, sequence analysis and identification of evolutionarily conserved domains. Hum. Mol. Genet., 4: 2265-2273, 1995.
13. Connor, F., Smith, A., Wooster, R., Stratton, M., Dixon, A., Campbell, E., Tait, T-M., Freeman, T., and Ashworth, A. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum. Mol. Genet., 6: 291-300, 1997.
14. Sharan, S. K., and Bradley, A. Murine Brca2: sequence, map position, and expression pattern. Genomics, 40: 234-341, 1997.
15. Winandy, S., Wu, P., and Georgopoulos, K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell, 83: 289-299, 1995.
16. Sah, V. P., Attardi, L. D., Mulligan, G. J., Williams, B. O., Bronson, R. T., and Jacks, T. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet., 10: 175-179, 1995.
17. Bonyadi, M., Rusholme, S. A. B., Cousins, F. M., Su, H. C., Biron, C. A., Farrall, M., and Akhurst, R. J. Mapping of a major genetic modifier of embryonic lethality in TGF β1 knockout mice. Nat. Genet., 15: 207-211, 1997.
18. Rajan, J. V., Marquis, S. T., Gardner, H. P., and Chodosh, L. A. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev. Biol., 184: 385-401, 1997.
19. Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., and Venkitaraman, A. R. Involvement of Brca2 in DNA repair. Molecular Cell, 1: 347-357, 1998.